Navigation Links
KV Pharmaceutical Company Reduces Workforce
Date:2/9/2009

randed drug subsidiary.

For further information about KV Pharmaceutical Company, please visit the Company's corporate Web site at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

The information in this release may contain various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning the operations, future results and prospects of K-V Pharmaceutical Company (the "Company"). Such statements may be identified by the use of words like "plans," "expect," "aim," "believe," "projects," "anticipates," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, market position, acquisitions, revenues, expenditures, resumption of manufacturing and distribution of products and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, the Company provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approval
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 ... personal growth and exploration through the presentation of ... for download in the Apple® App Store. NoteStream ... contribute compelling and informative content to the platform. ... gain new followers and expand audience reach, and ...
(Date:9/23/2014)... MA (PRWEB) September 23, 2014 Today ... Work to Life by Bringing Life to Work: ... Brower. , In the book, Brower proves that ... supports: the benefits, policies, and informal cultural practices that ... and work. Her research shows that the investment will ...
(Date:9/23/2014)... Steven Winter Associates, Inc. (SWA) is pleased to ... State of Connecticut – Fairchild Wheeler Multi-Magnet High School, ... honored by the Connecticut Green Building Council (CTGBC) at ... 2014 at Stepping Stones Museum, in Norwalk, CT. ... of the Institutional Award of Honor, Fairchild Wheeler Multi-Magnet ...
(Date:9/23/2014)... Ale Gicqueau, President and Chairman at ... Visualization for Clinical Trials at the upcoming Pharmaceutical ... on Friday, September 26, 2014. , PhUSE is ... inception, PhUSE has expanded from its roots as a ... for the discussion of topics encompassing the work of ...
(Date:9/23/2014)... Published by Nationwide Lifts, the book is designed to inspire ... mobility in a new way, using equipment that is affordable, ... that equipment and can bring mobility and freedom back ... business, I’ve seen so many people struggle with what to ... mobility issues,” said Andy Darnley, co-founder and president of Nationwide ...
Breaking Medicine News(10 mins):Health News:Calling All Experts: New Mobile Learning App Accepting Content Contributors 2Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 2Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 3Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 4Health News:Tracy Brower ‘Brings Work to Life’ in Her New Book, Published By Bibliomotion 5Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 2Health News:Steven Winter Associates’ Projects Receive 2014 Green Building Awards 3Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2Health News:Nationwide Lifts, America’s Leader in Home Elevators, Is Proud to Announce the Release of Its First Book, “Stair Lifts: Move Up, Not Out!” 2
... leading cancer organizations shows cancer death rates decreased on ... nearly twice the annual decrease of 1.1 percent per ... in the Annual Report to the Nation on the ... and Alaska Natives published online October 15, 2007 ( ...
... of serious impairments in both learning ability and social ... the most prevalent conditions in child psychiatry, and, undoubtedly, ... is conservatively estimated to occur in 3,07,5% of school-age ... yield estimates of up to 17% (Barbaresi et al., ...
... Painted Pink in Support of National ... for the Cure, DALLAS, Oct. 13 NASCAR ... for the Cure at today,s Bank of,America 500 race ... http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO ) Bobby Labonte,s #43, sponsored by ...
... Calif., Oct. 12 Yesterday,Governor Schwarzenegger signed into ... to service and extend benefits to children and ... permanency. One important bill in this,package of legislation ... the current system of group home care into ...
... Hutchinson Cancer Research Center in January, SEATTLE, Oct. 12 ... has released a list of 10 players, one,of whom will ... 2007 Hutch Award finalists are: -- Paul Byrd, Cleveland ... Hudson, Arizona Diamondbacks -- Raul Ibanez, Seattle Mariners ...
... http://www.medikeeper.com ), a leading provider of technology solutions ... Series A investment round,led by Hawaii-based venture capital ... by a team of entrepreneurs and medical,professionals with ... accessible online. Beginning with its flagship Personal Health ...
Cached Medicine News:Health News:Annual report to the nation finds cancer death rate decline doubling 2Health News:Annual report to the nation finds cancer death rate decline doubling 3Health News:Annual report to the nation finds cancer death rate decline doubling 4Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3Health News:General Mills' #43, M&M's #38 Driving Passionately Pink for the Cure at Lowe's Motor Speedway NASCAR Race 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 3Health News:Ten Finalists Chosen for 2007 Hutch Award 2Health News:MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor 2
(Date:9/22/2014)... , Sept. 22, 2014  Neuralstem, Inc. (NYSE MKT: CUR) ... investigator at Emory University, presented long-term follow up data ... stem cells in the treatment of amyotrophic lateral sclerosis ... which occurred at the Annual Symposium on ALS of ... , on Friday, and was not open to the ...
(Date:9/22/2014)... Pa. , Sept. 22, 2014  Olympus, ... innovative solutions for medical and surgical procedures, among ... a deal with Munich -based ... Kick ® Navigation. This agreement applies to ... for cross-disciplinary U.S. sales and all distribution outside ...
(Date:9/22/2014)... MEETING, Pa. , Sept. 22, 2014 /PRNewswire/ ... announced today it has initiated a phase I ... trial will evaluate the safety, tolerability, and immunogenicity ... 6 (HPV-6), which causes most aerodigestive cancers. ... nose, throat, vocal cords, and parts of the ...
Breaking Medicine Technology:Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4
... Mylan Inc. (Nasdaq: MYL ) today announced ... from the U.S. Food and Drug Administration (FDA) for its ... 8.5 mg, 17 mg, 25.5 mg and 34 mg. Mylan ... ANDA containing a Paragraph IV certification for Nisoldipine ER Tablets ...
... Inc. (Amex: AEN ), a developer of innovative ... it has executed an agreement for the sale of approximately ... share to two new institutional investors in a registered direct ... also receive warrants to purchase approximately 1.42 million shares of ...
Cached Medicine Technology:Adeona to Raise $4 Million in Registered Direct Offering 2Adeona to Raise $4 Million in Registered Direct Offering 3
Mini ReadySub-Cell GT Cell, includes buffer tank, lid and electrodes, leveling bubble; accommodates 8-well and 12-well mini ReadyAgarose gels...
The Large Gel Drying Kit dries gels using the same principal components as the DryEase Mini-Gel Drying System but can accommodate larger format gels or four mini-gels. A base is not required for asse...
... generations. Most gels can be dried by positioning ... gel dryer, covering them with wet semi-permeable cellophane ... the cellophane flat. Tut's Tombs also produce great ... somewhat larger than the gel to be dried. ...
... your data for future generations. Most gels can ... backing plate of our gel dryer, covering them ... over them to hold the cellophane flat. Tut's ... with an open area somewhat larger than the ...
Medicine Products: